期刊文献+

中国大陆地区基因1a亚型丙型肝炎病毒系统进化分析 被引量:4

Phylogenetic analysis of subgenotype 1a of hepatitis C virus in China's Mainland
原文传递
导出
摘要 目的明确我国大陆地区基因1a亚型丙型肝炎病毒系统进化的情况。方法收集慢性丙型肝炎患者的血清标本,采用逆转录-巢式PCR扩增HCV基因组部分NS5B区和(或)部分核心/E1区片段。根据测序结果构建系统进化树,分析大陆地区基因1a亚型丙型肝炎病毒系统进化情况。结果共收集全国23个中心共1 012例患者标本,其中970例标本分型成功,基因1a亚型患者4例。以美国国立卫生院丙型肝炎数据库中不同国家来源丙型肝炎病毒序列为参考构建系统进化树成功。系统进化分析提示,4株HCV 1a亚型部分NS5B区序列散在分布于进化树中的不同分支,来源于不同国家。结论基因1a型HCV由国外传播入我国,在中国丙型肝炎病毒感染者中所占比率低,在大陆地区随机流行。 Objective To investigate the phylogeny profile of subgenotype l a of hepatitis C virus in China's Mainland. Methods Serum samples and clinical data were collected from patients with chronic hepatitis C from 23 sites in China's Mainland. NSSB and/or Cote/El region for sequencing were amplified by RT-nested PCR. Phylogenetic tree which built with reference sequences from NIH HCV database and phylogeny profile of subgenotype la of hepatitis C virus in China's Mainland were analyzed. Results Serum sample and clinical data were collected from 1 012 enrolled patients with CHC. HCV subgenotype were identified in 970/1 012 patients. Total of 4 patients with subgenotype la were identified and phylogenetie tree were built with reference sequence for NIH HCV database. Phylogenetic analysis showed these 4 sugenotype la NSSB region sequences originated from different countries and scattered in different branches in the phylogenetie tree. Conclusions Subgenotype la of HCV in China's Mainland originated from abroad. The proportion of subgenotype la in all Chinese HCV subgenotypes is low and subgenotype la patients are scattered in China's Mainland, randomly.
出处 《中华实验和临床感染病杂志(电子版)》 CAS 2014年第4期5-7,共3页 Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
基金 中国肝炎防治基金会光辉基金资助项目(No.GHF20100207) 北京市优秀人才培养资助D类项目(No.2012D003034000030) 首都卫生发展科研专项项目(No.首发2011-2017-02)
关键词 肝炎病毒 丙型 基因型 系统进化分析 Hepatitis C virus Genotype Phylogenetie analysis
  • 相关文献

参考文献8

  • 1Smith DB, Bukh J, Kuiken C, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource[J]. Hepatology,2014,59(1):318-327. 被引量:1
  • 2Duan Z, Jia JD, Hou J, et al. Current challenges and the management of chronic hepatitis C in China's Mainland[J]. J Clin Gastroenterol,2014. [Epub ahead of print]. 被引量:1
  • 3丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 4Kuiken C, Simmonds P. Nomenclature and numbering of the hepatitis C virus[J]. Methods Mol Biol,2009,510(1):33-53. 被引量:1
  • 5Gu L, Tong W, Yuau M, et al. An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants[J]. J Clin Virol,2013,57(4):311-317. 被引量:1
  • 6Fu Y, Wang Y, Xia W, et al. New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors[J]. J Viral Hepat,2011,18(1):42-52. 被引量:1
  • 7Zhou Y, Wang X, Mao Q, et al. Changes in modes of hepatitis C infection acquisition and genotypes in southwest China[J]. J Clin Virol,2009,46(3):230-233. 被引量:1
  • 8European Assocation for The Study of The Liver. EASL clinical practice guidelines: management of hepatitis C virus infection[J]. J Hepatol,2014,60(2):392-420. 被引量:1

二级参考文献15

  • 1Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869. 被引量:1
  • 2Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698. 被引量:1
  • 3Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155. 被引量:1
  • 4Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18. 被引量:1
  • 5Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137. 被引量:1
  • 6Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12. 被引量:1
  • 7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144. 被引量:1
  • 8Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214. 被引量:1
  • 9Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081. 被引量:1
  • 10National Institute of Health Consensus Development Conference Panel Statenent. Management of hepatitis C[J].Hepatology, 2002,36(5 Suppl 1):S3- S20. 被引量:1

共引文献734

同被引文献41

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部